Tilray Brands (TLRY) EBT Margin (2017 - 2026)
Tilray Brands' (TLRY) quarterly EBT Margin came in at 18.23% in Q2 2026, up 60218.0% YoY from N/an in Q2 2025, and down 62.05% on a QoQ basis from 11.25% in Q1 2026.
Tilray Brands (TLRY) EBT Margin (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of EBT Margin data on file, last reported at 18.23% in Q2 2026.
- Quarterly EBT Margin rose 60218.0% year-over-year to 18.23% in Q2 2026, while the trailing twelve-month figure through May 2026 was 12.6% (up 26773.0% YoY) and the FY2026 annual result came in at 12.6%, up 26773.0% from the prior year.
- EBT Margin eased to 18.23% in Q2 2026, from 11.25% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 33.35% in Q1 2022 to a low of 828.75% in Q1 2023.
- A 5-year average of 140.37% and a median of 32.85% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin tumbled 86209 bps — and 2024, when it surged 77148 bps.
- Tracing TLRY's EBT Margin over 5 years: stood at 50.89% in 2022, then soared by 50 bps to 25.58% in 2023, then sank by 54 bps to 39.46% in 2024, then jumped by 53 bps to 18.37% in 2025, then grew by 1 bps to 18.23% in 2026.
- The last three EBT Margin figures came in at 18.23% (Q2 2026), 11.25% (Q1 2026), and 18.37% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | -18.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -18.23% |
| Feb 28, 2026 | -11.25% |
| Nov 30, 2025 | -18.37% |
| Aug 31, 2025 | -0.37% |
| May 31, 2025 | -620.41% |
| Feb 28, 2025 | -426.49% |
| Nov 30, 2024 | -39.46% |
| Aug 31, 2024 | -16.88% |
| May 31, 2024 | -18.71% |
| Feb 29, 2024 | -57.27% |
| Nov 30, 2023 | -25.58% |
| Aug 31, 2023 | -27.46% |
| May 31, 2023 | -60.64% |
| Feb 28, 2023 | -828.75% |
| Nov 30, 2022 | -50.89% |
| Aug 31, 2022 | -38.24% |
| May 31, 2022 | -301.06% |
| Feb 28, 2022 | 33.35% |
| Nov 30, 2021 | 0.08% |
| Aug 31, 2021 | -17.76% |